Rates, Predictors, and Outcomes of Ustekinumab Dose Escalation in Inflammatory Bowel Disease. Petrov JC, Al-Bawardy B, Alzahrani R, Mohamed G, et al. J Clin Gastroenterol 2024 Apr 10. doi: 10.1097/MCG.0000000000002003.

Read + Share

Amedeo Smart

Independent Medical Education

Petrov JC, Al-Bawardy B, Alzahrani R, Mohamed G, et al. Rates, Predictors, and Outcomes of Ustekinumab Dose Escalation in Inflammatory Bowel Disease. J Clin Gastroenterol 2024 Apr 10. doi: 10.1097/MCG.0000000000002003.
PMID: 38595134